Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Leading Spanish pharmaceutical packaging company joins Copapharm Europe

Copapharm Europe : 05 February, 2008  (New Product)
Artes Graficas Nekar, a leading Spanish pharmaceutical packaging specialist, has joined Europe-wide pharma packaging and service alliance Copapharm Europe.
Nekar has been acquired by Madrid-based investment group GED and EBN through their investment vehicle Cardboard Printing Holdings, which also purchased current Copapharm Europe shareholder, Icesa.

Following the acquisitions and merger, Nekar and Icesa will retain their existing trading names, but will develop their businesses strategically as a joint company. Nekar with Icesa will significantly increase Copapharm Europe’s strength in Spain, both companies having substantial market share there in Copapharm Europe’s core pharmaceutical and healthcare printing packaging supply sector. The other Copapharm Europe member in Spain is Pans, based in Barcelona.

Icesa was established in 1965 in Madrid, and Nekar was established in 1967. Each has the capacity to produce more than 500 million carton units per year. Both produce packaging for high added value markets including pharmaceutical and healthcare, cosmetic, perfumery, personal care and specific market niches in the food industry.

Copapharm Europe estimates that the combined pharmaceutical market share of the two Madrid-based companies is almost 15 per cent and all the Spanish Copapharm Europe companies will be able to increase their capabilities and overall production capacity as a result of this merger and acquisition.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo